RCT | Cefepime/Enmetazobactam vs. Piperacillin/Tazobactam in patients with complicated urinary tract infections.

Effect of Cefepime/Enmetazobactam vs Piperacillin/Tazobactam on Clinical Cure and Microbiological Eradication in Patients With Complicated Urinary Tract Infection or Acute Pyelonephritis: A Randomized Clinical Trial – JAMA (free for a limited period)

Editorial: Cefepime/Enmetazobactam for Complicated Urinary Tract Infections – JAMA (free for a limited period)

Commentary on Twitter

In pts w complicated UTI or acute pyelonephritis caused by gram-negative pathogens, cefepime/enmetazobactam, vs piperacillin/tazobactam, met criteria for noninferiority & superiority w respect to primary outcome of clin cure & microbiological eradication https://t.co/Pn1sZH07QJ

— JAMA (@JAMA_current) October 4, 2022